NTLA continues to strengthen across the daily, weekly, monthly, and quarterly charts.
In this update, I walk through the technical setup, key support and resistance levels, and why Intellia remains one of my highest-conviction biotech names.
Disclosure: I am long shares of NTLA. This video reflects my personal opinions and is not investment advice.
